In other countries
The same active substances on other registers, the same brand first.
- Surmontil 25 MG Comprimidos Recubiertos con PelículaSpain · 35 mg · comprimido · Neuraxpharm Spain S.L.U.Same form
- SurmontilItaly · Gocce orali, soluzione · Neuraxpharm Italy S.P.A.Same substance
- Surmontil 25MGTaiwan · 錠劑 · 法台化學股份有限公司Same substance
- Surmontil Injectable SolutionTaiwan · 注射劑 · 法台化學股份有限公司Same substance
- Trimipramine MaleateUnited States · 100MG BASE, 25MG BASE, 50MG BASE · capsule · Usl PharmaSame substance
- SurmontilUnited States · 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · capsule · Teva WomensSame substance
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Canada, Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Trimipramine
- Strength
- 25 MG
- Dosage form
- Tablet
- Route
- Oral
- Register
- Canada (Health Canada)
- Status
- Marketed
- Authorised
- 31 Dec 1987
- Registration
- DIN 00740802
- Marketing authorisation holder
- Aa Pharma INC
- ATC code
- N06AA06
- Group
- Nervous system
- Supply
- PRESCRIPTION